Shanghai Hile Bio-Technology Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 71.23 million compared to CNY 85.08 million a year ago. Revenue was CNY 71.23 million compared to CNY 85.08 million a year ago.

Net income was CNY 14.24 million compared to CNY 10.6 million a year ago. Basic earnings per share from continuing operations was CNY 0.02211 compared to CNY 0.01645 a year ago. Diluted earnings per share from continuing operations was CNY 0.02211 compared to CNY 0.01645 a year ago.